山西医科大学学报
山西醫科大學學報
산서의과대학학보
JOURNAL OF SHANXI MEDICAL UNIVERSITY
2015年
1期
1132-1135
,共4页
HSP90抑制剂%多发性骨髓瘤%U266细胞
HSP90抑製劑%多髮性骨髓瘤%U266細胞
HSP90억제제%다발성골수류%U266세포
HSP90 inhibitor%multiple myeloma%U266 cells
目的:探讨HSP90抑制剂17-AAG对人多发性骨髓瘤细胞增殖及HSP90蛋白表达的影响。方法采用MTT法检测HSP90抑制剂对人多发性骨髓瘤U266细胞增殖能力的影响;采用 Western blot检测不同浓度的 HSP90抑制剂17-AAG (0.001,0.01,0.1,1.0,10.0μmol/L)对人多发性骨髓瘤细胞中HSP90蛋白表达水平的影响。结果 HSP90抑制剂17-AAG对人多发性骨髓瘤细胞株U266细胞有剂量依赖性的增殖抑制作用(P<0.05),无时间依赖性的增殖抑制作用(P>0.05)。随着药物浓度的增加,HSP90蛋白水平的表达也逐渐下降。结论 HSP90抑制剂能剂量依赖性抑制人多发性骨髓瘤细胞增殖能力,同时下调人多发性骨髓瘤细胞株U266细胞中HSP90蛋白水平的表达。
目的:探討HSP90抑製劑17-AAG對人多髮性骨髓瘤細胞增殖及HSP90蛋白錶達的影響。方法採用MTT法檢測HSP90抑製劑對人多髮性骨髓瘤U266細胞增殖能力的影響;採用 Western blot檢測不同濃度的 HSP90抑製劑17-AAG (0.001,0.01,0.1,1.0,10.0μmol/L)對人多髮性骨髓瘤細胞中HSP90蛋白錶達水平的影響。結果 HSP90抑製劑17-AAG對人多髮性骨髓瘤細胞株U266細胞有劑量依賴性的增殖抑製作用(P<0.05),無時間依賴性的增殖抑製作用(P>0.05)。隨著藥物濃度的增加,HSP90蛋白水平的錶達也逐漸下降。結論 HSP90抑製劑能劑量依賴性抑製人多髮性骨髓瘤細胞增殖能力,同時下調人多髮性骨髓瘤細胞株U266細胞中HSP90蛋白水平的錶達。
목적:탐토HSP90억제제17-AAG대인다발성골수류세포증식급HSP90단백표체적영향。방법채용MTT법검측HSP90억제제대인다발성골수류U266세포증식능력적영향;채용 Western blot검측불동농도적 HSP90억제제17-AAG (0.001,0.01,0.1,1.0,10.0μmol/L)대인다발성골수류세포중HSP90단백표체수평적영향。결과 HSP90억제제17-AAG대인다발성골수류세포주U266세포유제량의뢰성적증식억제작용(P<0.05),무시간의뢰성적증식억제작용(P>0.05)。수착약물농도적증가,HSP90단백수평적표체야축점하강。결론 HSP90억제제능제량의뢰성억제인다발성골수류세포증식능력,동시하조인다발성골수류세포주U266세포중HSP90단백수평적표체。
Objective To investigate the effect of HSP90 inhibitor on cell proliferation and HSP90 protein expression of human multi-ple myeloma. Methods Effect of HSP90 inhibitor on U266 cell proliferation was detected by MTT. HSP90 protein expression level in human multiple myeloma cells was tested by Western blot after treated with different concentrations of HSP90 inhibitor 17-AAG(0. 001, 0. 01,0. 1,1. 0,10. 0 μmol/L). Results HSP90 inhibitor 17-AAG had a dose-dependent inhibitory effect on the proliferation of hu-man multiple myeloma cell line U266 cells(P<0. 05),but no time-dependent inhibition(P>0. 05). With the increase of drug concen-tration,the expression level of HSP90 protein also decreased gradually. Conclusion HSP90 inhibitor could dose-dependently inhibit multiple myeloma cell proliferation ability,and also decrease HSP90 protein expression in multiple myeloma cell line U266 cells.